| Literature DB >> 27936033 |
Pugalendhi Ganesh Kumar1, Muthu Subash Kavitha2, Byeong-Cheol Ahn3.
Abstract
This study describes a novel approach to reducing the challenges of highly nonlinear multiclass gene expression values for cancer diagnosis. To build a fruitful system for cancer diagnosis, in this study, we introduced two levels of gene selection such as filtering and embedding for selection of potential genes and the most relevant genes associated with cancer, respectively. The filter procedure was implemented by developing a fuzzy rough set (FR)-based method for redefining the criterion function of f-information (FI) to identify the potential genes without discretizing the continuous gene expression values. The embedded procedure is implemented by means of a water swirl algorithm (WSA), which attempts to optimize the rule set and membership function required to classify samples using a fuzzy-rule-based multiclassification system (FRBMS). Two novel update equations are proposed in WSA, which have better exploration and exploitation abilities while designing a self-learning FRBMS. The efficiency of our new approach was evaluated on 13 multicategory and 9 binary datasets of cancer gene expression. Additionally, the performance of the proposed FRFI-WSA method in designing an FRBMS was compared with existing methods for gene selection and optimization such as genetic algorithm (GA), particle swarm optimization (PSO), and artificial bee colony algorithm (ABC) on all the datasets. In the global cancer map with repeated measurements (GCM_RM) dataset, the FRFI-WSA showed the smallest number of 16 most relevant genes associated with cancer using a minimal number of 26 compact rules with the highest classification accuracy (96.45%). In addition, the statistical validation used in this study revealed that the biological relevance of the most relevant genes associated with cancer and their linguistics detected by the proposed FRFI-WSA approach are better than those in the other methods. The simple interpretable rules with most relevant genes and effectively classified samples suggest that the proposed FRFI-WSA approach is reliable for classification of an individual's cancer gene expression data with high precision and therefore it could be helpful for clinicians as a clinical decision support system.Entities:
Mesh:
Year: 2016 PMID: 27936033 PMCID: PMC5148587 DOI: 10.1371/journal.pone.0167504
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of gene expression datasets used for analysis.
| Dataset | #Genes | #Sam | #Cat | Source |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia (ALL) | 2526 | 248 | 6 | Yeoh et al., 2002 [ |
| Gastric Cancer (GC) | 4522 | 30 | 3 | Hippo et al., 2002[ |
| National Cancer Institute NCI60 (NCI) | 5244 | 61 | 8 | Dudoit et al., 2002 [ |
| Novartis (Nov) | 1000 | 103 | 4 | Su et al., 2002 [ |
| Brain_Tumor (BT) | 7129 | 42 | 5 | Pomeroy et al., 2002 [ |
| Glioblastoma(GB) | 12625 | 50 | 4 | Nutt et al., 2002 [ |
| Leukemia (Leu) | 5327 | 72 | 3 | Armstrong et al., 2002 [ |
| Endometrial Cancer (EC) | 1771 | 42 | 4 | Risinger et al., 2003 [ |
| Childhood (Ch) | 8280 | 60 | 4 | Li et al., 2003 [ |
| Bladder Carcinoma (BC) | 1203 | 40 | 3 | Dyrskjot et al., 2003 [ |
| Global Cancer Map with repeated measurements (GCM_RM) | 7129 | 123 | 11 | Yeung et al., 2003 [ |
| Lung Cancer1 (Lun1) | 10541 | 34 | 3 | Dehan et al., 2007 [ |
| Lung Cancer2 (Lun2) | 12600 | 181 | 2 | Gordon et al., 2002 [ |
| Prostate Cancer (Pro) | 12600 | 136 | 2 | Singh et al., 2002 [ |
| Ovary Cancer (Ova) | 15154 | 253 | 2 | Petricoin et al., 2002 [ |
| Diffuse Large B-Cell Lymphoma (DLB) | 5469 | 77 | 2 | Shipp et al., 2002 [ |
| Hypopharyngeal Cancer (Hypo) | 9021 | 38 | 2 | Cromer et al., 2004 [ |
| Breast Cancer (Bre) | 12625 | 24 | 2 | Chang et al., 2005[ |
| Breast / Colon Cancer (BCC) | 182 | 104 | 2 | Chowdary et al., 2006 [ |
| Colorectal Carcinoma (CC) | 2202 | 37 | 2 | Laiho et al., 2007 [ |
| Pancreatic Cancer (Pan) | 54614 | 52 | 2 | NCBI, 2009 [ |
| Kidney Carcinoma (KC) | 7457 | 36 | 2 | NCBI, 2009 [ |
#Genes: number of genes, #Sam: samples, #Cat: categories
Fig 1Architecture of the proposed FRFI-WSA approach for cancer gene expression data.
Fig 2Partitioning of input genes in fuzzy space.
Fig 3Representation of typical membership function (MF) points and rule set (RS) for FRBMS.
Distribution of the training and testing tumor data categories in the GCM_RM dataset.
| Tumor Category | Total No. of Samples | Actual | Considered | ||
|---|---|---|---|---|---|
| #Tr | #Te | #Tr | #Te | ||
| Breast | 7 | 7 | 0 | 4 | 3 |
| Lung | 6 | 4 | 2 | 4 | 2 |
| Colorectal | 10 | 7 | 3 | 7 | 3 |
| Lymphoma | 19 | 14 | 5 | 14 | 5 |
| Melanoma | 5 | 5 | 0 | 3 | 2 |
| Uterus | 9 | 7 | 2 | 7 | 2 |
| Leukemia | 29 | 23 | 6 | 23 | 6 |
| Renal | 8 | 5 | 3 | 5 | 3 |
| Pancreas | 7 | 7 | 0 | 4 | 3 |
| Mesothelioma | 11 | 8 | 3 | 8 | 3 |
| CNS | 12 | 9 | 3 | 9 | 3 |
| Overall Total | 123 | 96 | 27 | 88 | 35 |
#Tr: training data, #Te: testing data
FEC and FEPM values for gene AB002380_at of the GCM_RM dataset.
| FEC | S1 | S2 | … | S122 | S123 |
| Low | 0.1578 | 0.2536 | … | 0.1925 | 0.4265 |
| Medium | 0.5269 | 0.6321 | … | 0.5262 | 0.5241 |
| High | 0.9417 | 0.9259 | … | 0.4534 | 0.9321 |
| FEPM | S1 | S2 | … | S122 | S123 |
| Low | 0.1427 | 0.1426 | … | 0.1324 | 0.1758 |
| Medium | 0.7242 | 0.6321 | … | 0.5815 | 0.6519 |
| High | 0.9838 | 0.9162 | … | 0.9647 | 0.9235 |
S1….…S123: samples
Gene group significance and gene-gene severance values of the GCM_RM dataset.
| Gene No. | Gene ID | Gsig | Gsev |
|---|---|---|---|
| G1 | A28102_at | 0.193452 | |
| G2 | AB000114_at | 0.152567 | |
| G3 | AB000115_at | 0.124561 | |
| … | … | … | |
| G7128 | Z97054_xpt2_at | 0.156722 | |
| G7129 | Z97074_at | 0.112345 |
Gsig: Gene significance, Gsev: Gene severance
Fig 4The F-information (FI) values of first hundred genes for GCM_RM dataset.
The rule set generated for the GCM_RM dataset by the FRFI-WSA method.
| Rule No. | Rule Set |
|---|---|
| R1 | If (PDCD1 & OGDH) are low and MG81 is medium, then it is Breast cancer. |
| R2 | If (PRMT1 & LGALS9) are medium and (X03453 & RAD51) are high, then it is Breast cancer. |
| R3 | If (GLO1 & SLC25A13) are high and PRKAR1A is low, then it is Breast cancer. |
| R4 | If J04423 is high, and GLO1 is low, and NCOR2 is high, then it is Lung cancer. |
| R5 | If (RYR1 & SLC25A13) are low and (RAD51 & PRKAR1A) are medium, then it is Lung cancer. |
| R6 | If NOP14-AS1 is high and (J04423 & NCOR2) are medium, then it is Colorectal cancer. |
| R7 | If (PDCD1 & OGDH) are medium and MG81 is low, then it is Colorectal cancer. |
| R8 | If J04423 is low and RBM42 is high, then it is Lymphoma. |
| R9 | If PRMT1 is high and, (X03453 & LGALS9) are low, then it is Lymphoma. |
| R10 | If (RYR1 & RBM42) are medium and PDCD1 is high, then it is Melanoma. |
| R11 | If (GLO1 & PRKAR1A) are medium and PDCD1 is low, then it is Melanoma. |
| R12 | If NOP14-AS1 is low and (J04423 & M24537B) are high, then it is Uterine cancer. |
| R13 | If (PRMT1 & LGALS9) are high and (X03453 & RAD51) are medium, then it is Uterine cancer. |
| R14 | If J04423 is medium and GLO1 is high and MG81 is low, then it is Uterine cancer. |
| R15 | If NOP14-AS1 is high and M24537B is medium, then it is Leukemia. |
| R16 | If (PDCD1 & OGDH) are medium and NCOR2 is low, then it is Leukemia. |
| R17 | If PRMT1 is medium and (X03453 & LGALS9) are low, then it is Renal cancer. |
| R18 | If J04423 is high, and RBM42 is medium and OGDH is low, then it is Renal cancer. |
| R19 | If (RYR1 & SLC25A13) are medium and (RAD51 & PRKAR1A) are high, then it is Renal cancer. |
| R20 | If (PRMT1 & NCOR2) are low and NOP14-AS1 is medium, then it is Pancreatic cancer. |
| R21 | If X03453 is medium and (RBM42 & M24537B) are low, then it is Pancreatic cancer. |
| R22 | If RYR1 is low and (MG81 & PDCD1) are high, then it is Pancreatic cancer. |
| R23 | If PRMT1 is low and X03453 is high, and LGALS9 is medium, then it is Mesothelioma. |
| R24 | If PRMT1 is low and (X03453 & LGALS9) are high, then it is Mesothelioma. |
| R25 | If (PRKAR1A & SLC25A13) are high and (NOP14-AS1 & RAD51) are low, then it is CNS cancer. |
| R26 | If (J04423 & M24537B) are low and (RYR1 & OGDH) are high, then it is CNS cancer. |
Identification of the most significant genes and their linguistic label in the rule set for the classification of tumor categories for the GCM_RM dataset by FRFI-WSA.
| Gene Name | Linguistic Label | ||
|---|---|---|---|
| Low | Medium | High | |
| RBM42 | Pancreas | Melanoma/Renal | Lymphoma |
| SLC25A13 | Lung | Renal | Breast/CNS |
| J04423 | CNS | Colorectal | Uterus |
| X03453 | Lymphoma/Renal | Uterus/Pancreas | Breast/Mesothelioma |
| NOP14-AS1 | CNS/Uterus | Pancreas | Colorectal/Leukemia |
| M24537B | CNS/Pancreas | Leukemia | Uterus |
| OGDH | Breast/ Renal | Colorectal/Leukemia | CNS |
| GLO1 | Lung | Melanoma | Breast/Uterus |
| RAD51 | CNS | Lung/Uterus | Breast/Renal |
| NCOR2 | Pancreas/Leukemia | Colorectal | Lung |
| PDCD1 | Breast/Melanoma | Colorectal/Leukemia | Melanoma/Pancreas |
| PRMT1 | Mesothelioma/Pancreas | Breast/Renal | Lymphoma/Uterus |
| LGALS9 | Lymphoma/ Renal | Breast/Mesothelioma | Uterus/ Mesothelioma |
| PRKAR1A | Breast | Lung/Melanoma | Renal/CNS |
| RYR1 | Lung/Pancreas | Melanoma/Renal | CNS |
| MG81 | Colorectal/Uterus | Breast | Pancreas |
Fig 5Convergence comparison of WSA with other methods for GCM_RM dataset.
Comparison of the performance of the water swirl algorithm with existing methods on all datasets.
| DS | #Gs | CA% | CTs | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GA | PSO | ABC | WSA | GA | PSO | ABC | WSA | GA | PSO | ABC | WSA | |
| ALL | 41 | 38 | 35 | 23 | 84.23 | 88.42 | 92.78 | 95.12 | 321.45 | 298.43 | 194.65 | 173.42 |
| GC | 38 | 34 | 33 | 26 | 86.87 | 92.41 | 94.76 | 95.23 | 312.45 | 284.87 | 223.45 | 165.98 |
| NCI | 40 | 39 | 29 | 22 | 84.69 | 87.45 | 91.28 | 96.89 | 292.43 | 290.14 | 264.52 | 187.56 |
| Nov | 42 | 37 | 32 | 24 | 85.89 | 87.43 | 91.67 | 95.64 | 296.31 | 278.23 | 250.42 | 176.43 |
| BT | 34 | 34 | 28 | 19 | 87.25 | 90.45 | 89.45 | 95.12 | 218.46 | 188.35 | 158.25 | 121.49 |
| GB | 36 | 33 | 36 | 26 | 83.96 | 87.45 | 91.23 | 96.42 | 267.35 | 243.76 | 186.12 | 156.81 |
| Leu | 32 | 29 | 27 | 24 | 84.56 | 87.56 | 90.58 | 96.79 | 291.43 | 258.43 | 192.23 | 157.56 |
| EC | 39 | 37 | 36 | 24 | 84.12 | 86.49 | 92.56 | 96.12 | 246.71 | 217.38 | 183.46 | 162.53 |
| Ch | 38 | 37 | 30 | 23 | 86.45 | 82.45 | 92.47 | 95.12 | 245.83 | 221.64 | 193.46 | 153.29 |
| BC | 42 | 38 | 33 | 27 | 90.15 | 89.61 | 92.49 | 94.19 | 257.14 | 243.87 | 225.32 | 196.78 |
| GCM_RM | 32 | 29 | 26 | 18 | 84.59 | 85.67 | 90.56 | 96.45 | 294.12 | 256.45 | 198.25 | 165.54 |
| Lun1 | 45 | 42 | 34 | 29 | 91.32 | 93.23 | 90.46 | 94.71 | 258.98 | 247.32 | 194.85 | 153.59 |
| Lun2 | 38 | 36 | 35 | 32 | 83.48 | 85.29 | 90.59 | 96.87 | 238.14 | 195.42 | 168.12 | 148.12 |
| Pro | 25 | 22 | 19 | 12 | 84.52 | 86.47 | 90.32 | 95.73 | 262.14 | 205.46 | 171.31 | 124.12 |
| Ova | 26 | 21 | 18 | 12 | 87.29 | 94.36 | 95.54 | 98.56 | 258.69 | 201.13 | 187.89 | 143.65 |
| DLB | 21 | 19 | 17 | 14 | 84.78 | 92.57 | 94.87 | 97.45 | 294.78 | 268.59 | 237.56 | 165.87 |
| Hypo | 39 | 35 | 31 | 27 | 85.43 | 81.26 | 91.49 | 98.23 | 295.67 | 287.45 | 163.67 | 151.25 |
| Bre | 38 | 35 | 29 | 23 | 83.25 | 88.49 | 93.21 | 96.46 | 284.35 | 256.45 | 218.34 | 187.19 |
| BCC | 27 | 29 | 24 | 21 | 84.58 | 88.19 | 93.45 | 98.76 | 275.34 | 263.46 | 246.12 | 223.14 |
| CC | 25 | 21 | 17 | 14 | 86.43 | 89.12 | 93.14 | 96.34 | 275.87 | 251.23 | 231.98 | 201.49 |
| Pan | 15 | 12 | 10 | 7 | 89.49 | 94.26 | 95.12 | 98.29 | 247.36 | 203.62 | 168.23 | 114.29 |
| KC | 28 | 24 | 19 | 16 | 85.48 | 91.26 | 95.45 | 96.82 | 283.28 | 271.54 | 236.42 | 178.56 |
DS: dataset, #GS: number of genes, CA: classification accuracy, CT: central processing unit time
Fig 6Generalization ability of WSA for GCM_RM dataset.
Comparison of the performance of the water swirl algorithm with existing methods by Wilcoxon’s signed rank test on all datasets.
| Comparison | GA Vs WSA | PSO Vs WSA | ABC Vs WSA | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of Rules | 5 | 86 | 0.53 | 6 | 61 | 0.62 | 3 | 62 | 0.31 | |||
| No. of Genes | 6 | 78 | 0.45 | 7 | 86 | 0.53 | 5 | 65 | 0.51 | |||
| Accuracy | 2 | 51 | 0.56 | 4 | 48 | 0.82 | 6 | 67 | 0.75 | |||
| Interpretability | 6 | 75 | 0.91 | 12 | 56 | 0.63 | 11 | 69 | 0.79 | |||
| CPU Time | 8 | 71 | 0.56 | 18 | 38 | 0.51 | 13 | 56 | 0.76 | |||
Fig 7Receiver operating characteristics curve analysis for selected datasets by FRFI-WSA.
Reliability analysis of the rule set generated by FRFI-WSA in all datasets.
| ALL | 22 | 15.87 | 85.46 | 0.182 | 5.31 | 10.19 | 0.432 |
| GC | 31 | 14.98 | 87.43 | 0.453 | 9.76 | 7.46 | 0.652 |
| NCI | 19 | 12.40 | 82.37 | 0.517 | 7.22 | 9.37 | 0.598 |
| Nov | 18 | 13.69 | 82.34 | 0.431 | 7.23 | 10.15 | 0.532 |
| BT | 11 | 11.02 | 84.75 | 0.795 | 5.91 | 8.34 | 0.567 |
| GB | 15 | 11.78 | 84.19 | 0.639 | 8.41 | 9.57 | 0.591 |
| Leu | 8 | 14.49 | 82.09 | 0.765 | 6.98 | 8.35 | 0.687 |
| EC | 9 | 15.76 | 86.34 | 0.653 | 9.54 | 9.16 | 0.639 |
| Ch | 9 | 14.67 | 86.71 | 0.652 | 8.56 | 10.21 | 0.546 |
| BC | 11 | 11.78 | 89.32 | 0.693 | 9.21 | 9.45 | 0.586 |
| GCM_RM | 26 | 12.69 | 83.39 | 0.823 | 6.92 | 9.95 | 0.535 |
| Lun1 | 23 | 15.87 | 84.99 | 0.754 | 8.46 | 8.42 | 0.462 |
| Lun2 | 7 | 10.40 | 80.68 | 0.546 | 7.70 | 8.49 | 0.536 |
| Pro | 5 | 11.76 | 82.09 | 0.576 | 7.20 | 9.46 | 0.621 |
| Ova | 9 | 16.82 | 84.62 | 0.679 | 5.23 | 9.20 | 0.503 |
| DLB | 8 | 18.47 | 84.16 | 0.959 | 5.60 | 8.06 | 0.530 |
| Hypo | 11 | 16.45 | 85.12 | 0.643 | 7.34 | 9.12 | 0.513 |
| Bre | 12 | 16.18 | 83.23 | 0.798 | 6.45 | 9.82 | 0.653 |
| BCC | 9 | 16.23 | 86.54 | 0.475 | 8.67 | 10.23 | 0.543 |
| CC | 10 | 18.41 | 88.45 | 0.467 | 6.813 | 9.14 | 0.614 |
| Pan | 9 | 10.48 | 83.67 | 0.562 | 5.05 | 9.48 | 0.634 |
| KC | 7 | 11.44 | 84.37 | 0.498 | 7.64 | 8.45 | 0.597 |
DS: datasets, #R: rules, R: coverage of the rules, R: accuracy of the rules, R: goodness of the rules, A: average rule length, A: average fired rules, A: average confidence firing degree of the rules
Fig 8Comprehensibility of the generated rules by WSA for GCM_RM dataset.